Atlas market file · Etf · United States
Portfolio Building Block World Pharma and Biotech Index ETFPBPH
- Last close
- 27.9841
- Change
- -0.57%
- 96-bar range
- 24.241 – 28.25
- As of
- 12 Aug 2026
Portfolio Building Block World Pharma and Biotech Index ETF is an exchange-traded fund listed as PBPH on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
PBPH
Etf · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 38 weekly closes (+13.50% over the window).
Source rail: Yahoo Finance chart API (PBPH). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for PBPH. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
PBPH public profile
Exchange-traded fund. Portfolio Building Block World Pharma and Biotech Index ETF is connected to current market context, cited company sources and its retained research file.
Portfolio Building Block World Pharma and Biotech Index ETF trades as PBPH on NASDAQ. Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) has a latest verified close of 27.9841, down 0.57%, dated 12 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. PBPH stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Portfolio Building Block World Pharma and Biotech Index ETF today
The PBPH ETF (Portfolio Building Block World Pharma and Biotech Index ETF) listed on Nasdaq maintains a 0.45% expense ratio while holding a top-heavy portfolio dominated by five pharmaceutical giants accounting for 48% of assets, per SEC filings and FINRA analysis.
Despite marketing language emphasizing 'global innovation exposure,' the fund’s actual mandate allows significant concentration risk, with Johnson & Johnson, Roche, Pfizer, AbbVie, and Eli Lilly forming nearly half its holdings. The ETF’s liquidity profile shows modest average daily trading volume of 12,000 shares, raising questions about execution ease during market stress.
SEC EDGAR documents outline PBPH’s 'sampling replication' methodology, which permits deviation from full index replication under unspecified conditions, creating potential tracking discrepancies. No recent earnings or portfolio rebalancing filings were identified in the latest EDGAR search as of 2026-07-28.
The fund’s prospectus dedicates extensive space to thematic benefits but provides minimal detail on risk management protocols for its concentrated approach. Investors relying on PBPH for diversification may find themselves more exposed to large-cap pharma volatility than advertised.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
PBPH technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on PBPH
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep PBPH research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
PBPH FAQ
What is Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)?Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) has a latest verified close of 27.9841, down 0.57%, dated 12 Aug 2026. Use this page to check the...
Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) has a latest verified close of 27.9841, down 0.57%, dated 12 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for PBPH?Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) has a latest verified close of 27.9841, down 0.57%, dated 12 Aug 2026. It brings the latest available...
Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) has a latest verified close of 27.9841, down 0.57%, dated 12 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. PBPH stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the PBPH page updated?The PBPH public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The PBPH public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for PBPH?The PBPH file starts with Nasdaq Trader and TradingView NASDAQ:PBPH. The page separates verified market context from company evidence and shows open evidence gaps...
The PBPH file starts with Nasdaq Trader and TradingView NASDAQ:PBPH. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on PBPH?Yes. The workstation can open PBPH, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open PBPH, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this PBPH page investment advice?No. The PBPH page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The PBPH page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →